New Delhi [India], May 28 (ANI): The All India Council for Technical Education (AICTE) and the Council of Scientific and Industrial Research (CSIR) have embarked on a drug discovery hackathon to fight against COVID-19, said Prof K Vijay Raghavan, Principal Scientific Advisor (PSA) to Gove
New Delhi [India], May 27 (ANI): The Council for Scientific and Industrial Research (CSIR) has signed an MoU with Reliance to develop a new RT-LAMP COVID-19 diagnostic kit, which is cheap and gives a quick result, said Director-General Dr Shekhar C Mande on Wednesday.
New Delhi [India], May 27 (ANI): Director General of the Council of Scientific and Industrial Research (CSIR), Shekher Mande, on Wednesday said the Indian Council of Medical Research's (ICMR) conclusion of hydroxychloroquine (HCQ) having no major side-effects in the treatment of Covid-inf
New Delhi [India], May 27 (ANI): Dismissing the reports of health risks from Hydroxychloroquine (HCQ) as per simmering reports cited by the World Health Organisation (WHO), Shekher Mande, Director General of the Council of Scientific and Industrial Research (CSIR), India, said on Wednesday t
New Delhi [India], May 21 (ANI): Three drug trials to combat COVID-19 have started and seven are in the process, said Council of Scientific and Industrial Research (CSIR) Director-General (DG) Dr Shekhar C Mande on Thursday.
New Delhi [India], May 13 (ANI): The AYUSH Ministry and the Council of Scientific and Industrial Research (CSIR) are working together on validating four Ayush formulations against COVID-19 and the trials will start within one week.
New Delhi [India], May 12 (ANI): In a record time of just 36 days a non-invasive BiPAP Ventilator 'SwasthVayu' has been developed by CSIR - National Aerospace Laboratories (NAL), Bangalore, a constituent of lab of CSIR to treat COVID-19 patients.
New Delhi [India], May 8 (ANI): The Council for Scientific and Industrial Research (CSIR) is leading the fight against Covid-19 using multi-pronged approach and multiple models of engagement.On one hand, CSIR labs themselves are developing technologies and products and are working with indus
New Delhi [India], May 8 (ANI): The Council of Scientific and Industrial Research (CSIR), through its New Millennium Indian Technology Leadership Initiative (NMITLI) program, has approved a multi-institutional project to develop human monoclonal antibodies (hmAbs) that can neutralize coronav
New Delhi [India], May 8 (ANI): The Council for Scientific and Industrial Research (CSIR) has received approval from Drug Controller General of India (DGCI) for its two clinical trial drugs - 'favipiravir' and 'phytopharmaceutical' - to combat coronavirus.
Hyderabad (Telangana) [India], May 8 (ANI): The Council of Scientific and Industrial Research (CSIR), under its flagship New Millennium Indian Technology Leadership Initiative programme (NMITLI), has sanctioned a project to develop human monoclonal antibodies as therapy for COVID-19 infectio
New Delhi [India], May 7 (ANI): The Council for Scientific and Industrial Research (CSIR) is exploring a native herb as a biological medicine or "phytopharmaceutical ", which is already being tested as medicine for dengue, for its efficacy to combat COVID-19.